Walther Helmut Wernsdorfer

Walther Helmut Wernsdorfer's AcademicInfluence.com Rankings

Biology

#13548

World Rank

#17100

Historical Rank

Microbiology

#844

World Rank

#926

Historical Rank

biology Degrees

Download Badge

Biology

Why Is Walther Helmut Wernsdorfer Influential?

(Suggest an Edit or Addition)

(See a Problem?)

Walther Helmut Wernsdorfer's Published Works

Number of citations in a given year to any of this author's works

Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author

Published Works

A review of malaria diagnostic tools: microscopy and rapid diagnostic test (RDT). (2007) (896)
Malaria: Principles and Practice of Malariology (1989) (660)
Epidemiology of drug-resistant malaria. (2002) (531)
From malaria control to eradication: The WHO perspective (2009) (290)
Epidemiology of drug resistance in malaria. (1994) (270)
Chemotherapy of malaria (1987) (268)
The epidemiology of human malaria as an explanation of its distribution, including some implications for its control. (1988) (238)
The dynamics of drug resistance in Plasmodium falciparum. (1991) (213)
Histidine-Rich Protein II: a Novel Approach to Malaria Drug Sensitivity Testing (2002) (201)
The development and spread of drug-resistant malaria. (1991) (180)
Malaria drug-sensitivity testing: new assays, new perspectives. (2003) (165)
High level of resistance of Plasmodium falciparum to sulfadoxine-pyrimethamine in children in Tanzania. (1996) (163)
Mathematical models for transmission and control of malaria. (1988) (149)
Malaria epidemiology in the province of Moyen Ogoov, Gabon. (1995) (148)
The clinical features of malaria. (1988) (139)
History of malaria from prehistory to eradication. (1988) (105)
Malaria parasites of man: life-cycles and morphology (excluding ultrastructure). (1988) (97)
A phase-III clinical trial of mefloquine in children with chloroquine-resistant falciparum malaria in Thailand. (1987) (91)
The microscopic diagnosis of malaria. (1988) (87)
Clinical study of pyronaridine for the treatment of acute uncomplicated falciparum malaria in Thailand. (1996) (80)
Effects of Miltefosine and Other Alkylphosphocholines on Human Intestinal ParasiteEntamoeba histolytica (2001) (78)
The epidemiology of malaria and its measurement. (1988) (77)
Molecular markers for drug resistance in malaria: use in treatment, diagnosis and epidemiology (2003) (76)
In Vitro Interactions of Artemisinin with Atovaquone, Quinine, and Mefloquine against Plasmodium falciparum (2002) (76)
The importance of malaria in the world. (1980) (72)
A histidine-rich protein 2-based malaria drug sensitivity assay for field use. (2004) (69)
Thrombocyte counts in mice after the administration of papaya leaf suspension (2009) (67)
Sensitivity to quinine and mefloquine of Plasmodium falciparum in Thailand. (1986) (66)
Coartemether (artemether and lumefantrine): an oral antimalarial drug (2004) (65)
A phase II clinical trial of mefloquine in patients with chloroquine-resistant falciparum malaria in Thailand. (1983) (65)
Pentoxifylline as an ancillary treatment for severe falciparum malaria in Thailand. (1998) (64)
In vitro activity of quinolines against Plasmodium falciparum in Gabon. (2004) (64)
Reassessment of the resistance of Plasmodium falciparum to chloroquine in Gabon: implications for the validity of tests in vitro vs. in vivo. (2002) (62)
Severe and complicated malaria. World Health Organization Malaria Action Programme. (1986) (59)
Emergence of multidrug-resistant Plasmodium falciparum in Thailand: in vitro tracking. (1992) (59)
In vitro sensitivity of Plasmodium falciparum to artesunate in Thailand. (1999) (57)
Plasmodium falciparum: effect of anti-malarial drugs on the production and secretion characteristics of histidine-rich protein II. (2002) (57)
Major animal models in malaria research: rodent. (1988) (57)
A randomized, double-blind, comparative trial of a new oral combination of artemether and benflumetol (CGP 56697) with mefloquine in the treatment of acute Plasmodium falciparum malaria in Thailand. (1999) (56)
The global distribution of malaria and the present control effort. (1988) (55)
Synergism of benflumetol and artemether in Plasmodium falciparum. (1999) (54)
Determination of a new antimalarial drug, benflumetol, in blood plasma by high-performance liquid chromatography. (1996) (50)
Sensitivity of Plasmodium vivax to chloroquine in Sa Kaeo Province, Thailand. (2002) (49)
Lack of effect of desipramine on the response to chloroquine of patients with chloroquine-resistant falciparum malaria. (1992) (49)
Unexpected frequency, duration and spectrum of adverse events after therapeutic dose of mefloquine in healthy adults. (2002) (48)
An in vitro system for assessing the sensitivity of Plasmodium vivax to chloroquine. (2002) (47)
Parasite density of Plasmodium falciparum malaria in Ghanaian schoolchildren: evidence for influence of sex hormones? (1994) (47)
Drug sensitivity tests in malaria parasites. (1988) (46)
Serial studies on the evolution of chloroquine resistance in an area of East Africa receiving intermittent malaria chemosuppression. (1985) (46)
Field evaluation of drug resistance in malaria. In vitro micro-test. (1980) (46)
Plasmodium falciparum: in vitro interactions of artemisinin with amodiaquine, pyronaridine, and chloroquine. (2002) (46)
Plasmodium falciparum: susceptibility in vitro and in vivo to chloroquine and sulfadoxine-pyrimethamine in Ghanaian schoolchildren. (1994) (41)
Desbutyl-Benflumetol, a Novel Antimalarial Compound: In Vitro Activity in Fresh Isolates of Plasmodium falciparumfrom Thailand (2001) (40)
Major animal models in malaria research: simian. (1988) (40)
Specific immunity: acquired in man. (1988) (40)
Drug sensitivity of Plasmodium falciparum in Gabon. Activity correlations between various antimalarials. (1994) (40)
Single dose pharmacokinetics of oral artemether in healthy Malaysian volunteers. (1997) (39)
In vitro activity of tafenoquine alone and in combination with artemisinin against Plasmodium falciparum. (2002) (39)
Malaria at the turn from the 2nd to the 3rd millenium. (2003) (38)
Soluble intercellular adhesion molecule-1 (ICAM-1), endothelial leukocyte adhesion molecule-1 (ELAM-1), and tumor necrosis factor receptor (55 kDa TNF-R) in patients with acute Plasmodium falciparum malaria. (1994) (37)
Mefloquine concentration profiles during prophylactic dose regimens. (2000) (36)
Clinical-parasitological response and in-vitro sensitivity of Plasmodium vivax to chloroquine and quinine on the western border of Thailand. (2006) (34)
Activity of Eurycoma longifolia root extract against Plasmodium falciparum in vitro (2009) (34)
Activity of benflumetol and its enantiomers in fresh isolates of Plasmodium falciparum from East Africa. (1998) (34)
Effect of pentoxifylline on cytokine patterns in the therapy of complicated Plasmodium falciparum malaria. (1998) (33)
Single dose kinetic study of the triple combination mefloquine/sulphadoxine/pyrimethamine (Fansimef) in healthy male volunteers. (1989) (33)
An epidemic of Plasmodium falciparum malaria in Balcad, Somalia, and its causation. (1995) (33)
Declining chloroquine resistance of Plasmodium falciparum in Lambaréné, Gabon from 1992 to 1998. (2001) (32)
Mefloquine, sulfadoxine, and pyrimethamine in the treatment of symptomatic falciparum malaria: a double-blind trial for determining the most effective dose. (1987) (32)
Follow-up of the susceptibility of Plasmodium falciparum to antimalarials in Gabon. (1998) (32)
A symposium on containment of mefloquine-resistant falciparum malaria in Southeast Asia with special reference to border malaria. (1994) (31)
Susceptibility of Plasmodium falciparum in vitro to chloroquine, mefloquine, quinine and sulfadoxine/pyrimethamine in Somalia: relationships between the responses to the different drugs. (1991) (31)
Plasmodium falciparum-malaria: resistance to chloroquine, but sensitivity to mefloquine in the Gabon. A prospective in-vitro study. (1984) (30)
Pharmacokinetics and bioequivalence evaluation of three commercial tablet formulations of mefloquine when given in combination with dihydroartemisinin in patients with acute uncomplicated falciparum malaria (2000) (30)
The treatment and prophylaxis of malaria. (1988) (29)
In vitro drug sensitivity of Plasmodium falciparum in Acre, Brazil. (1989) (29)
Resistance to chloroquine and sulfadoxine-pyrimethamine in Plasmodium falciparum in Muheza district, Tanzania. (1999) (27)
Chloroquine resistance of Plasmodium falciparum: a biological advantage? (1995) (27)
Recent progress of malaria research: chemotherapy. (1988) (26)
Frequency distribution of antimalarial drug resistance alleles among Plasmodium falciparum isolates from Gezira State, central Sudan, and Gedarif State, eastern Sudan. (2010) (26)
In Vitro Activity and Interaction of Clindamycin Combined with Dihydroartemisinin against Plasmodium falciparum (2003) (26)
A malariometric survey in a rural community in the Muheza district, Tanzania: age profiles in the development of humoral immune responses. (1997) (25)
Pharmacodynamic interactions among atovaquone, proguanil and cycloguanil against Plasmodium falciparum in vitro. (2003) (25)
Antimalarial activity of azithromycin, artemisinin and dihydroartemisinin in fresh isolates of Plasmodium falciparum in Thailand. (2001) (25)
Plasmodial metabolism and related organellar function during various stages of the life-cycle: proteins, lipids, nucleic acids and vitamins. (1988) (25)
Drug-resistant malaria--occurrence, control, and surveillance. (1980) (24)
In vivo-in vitro model for the assessment of clinically relevant antimalarial cross-resistance. (2001) (23)
Declining mefloquine sensitivity of Plasmodium falciparum along the Thai-Myanmar border. (2004) (23)
Molecular epidemiology of drug resistance markers of Plasmodium falciparum malaria in Thailand (2005) (22)
Efficacy of artemisinin and mefloquine combinations against Plasmodium falciparum. In vitro simulation of in vivo pharmacokinetics (1997) (22)
In vitro response of chloroquine-resistant Plasmodium falciparum to mefloquine. (1979) (22)
The histopathology of malaria. (1988) (22)
Isolated malaria outbreak in Somalia: role of chloroquine-resistant Plasmodium falciparum demonstrated in Balcad epidemic. (1990) (22)
Synergism between Amodiaquine and Its Major Metabolite, Desethylamodiaquine, against Plasmodium falciparum In Vitro (2004) (21)
Plasmodial metabolism and related organellar function during various stages of the life-cycle: carbohydrates. (1988) (21)
Clinical and molecular characterization of a near fatal case of human babesiosis in Austria. (2010) (21)
The effect of artemisinin on granulocyte function assessed by flow cytometry. (1997) (21)
Relative bioavailability of the hydrochloride, sulphate and ethyl carbonate salts of quinine. (1988) (21)
The malaria situation in 1976. (1978) (20)
Malaria and Nutrition (1936) (20)
Pharmacodynamic Interaction of Doxycycline and Artemisinin in Plasmodium falciparum (2002) (20)
A new and simple solid-phase extraction method for LC determination of pyronaridine in human plasma. (2005) (19)
Use of the in vitro microtechnique for the assessment of drug sensitivity of Plasmodium falciparum in Sennar, Sudan. (1980) (19)
Pharmacodynamic interactions of amodiaquine and its major metabolite desethylamodiaquine with artemisinin, quinine and atovaquone in Plasmodium falciparum in vitro. (2005) (18)
Plasma concentrations of sulfadoxine in healthy and malaria infected Thai subjects. (1988) (17)
Positive relationship between the response of Plasmodium falciparum to chloroquine and pyronaridine. (1991) (17)
Differences in drug response of Plasmodium falciparum within an area of the Amazon region. (1989) (17)
In vitro sensitivity of multiresistant Plasmodium falciparum to new candidate antimalarial drugs in western Thailand. (1990) (17)
In vitro cultivation of malaria parasites: exoerythrocytic stages. (1988) (17)
Fine structure of malaria parasites in the various stages of development. (1988) (17)
Sensitivity to artemisinin, mefloquine and quinine of Plasmodium falciparum in northwestern Thailand (2010) (16)
A double-blind clinical trial of a combination of mefloquine, sulfadoxine and pyrimethamine in symptomatic falciparum malaria. (1985) (16)
Malaria drug-susceptibility testing. HRP2-based assays: current data, future perspectives. (2003) (16)
In vitro sensitivity of Plasmodium falciparum and clinical response to lumefantrine (benflumetol) and artemether. (2000) (16)
The changing pattern of Plasmodium falciparum susceptibility to chloroquine but not to mefloquine in a mesoendemic area of Somalia. (1991) (16)
Activity of selected phytochemicals against Plasmodium falciparum. (2012) (15)
The biological and epidemiological basis of drug resistance in malaria parasites. (1992) (15)
In vitro sensitivity of Plasmodium falciparum isolates in Thailand to quinine and chloroquine, 1984-1990. (1992) (14)
Inverse correlation of sensitivity in vitro of Plasmodium falciparum to chloroquine and mefloquine in Ghana. (1994) (14)
The differential diagnosis of malaria. (1988) (13)
Specific immunity: immunopathology and immunosuppression. (1988) (13)
In vitro activity of artemisinin alone and in combination with retinol against Plasmodium falciparum (2005) (12)
Susceptibility of Plasmodium falciparum to chloroquine and mefloquine in Somalia. (1988) (12)
Activity correlation between artemisinin and dihydro-artemisinin in fresh isolates of Plasmodium falciparum from Thailand. (2000) (12)
Genetically determined human resistance factors. (1988) (12)
Development of a blood culture medium and a standard in vitro microtest for field-testing the response of Plasmodium falciparum to antifolate antimalarials. (1989) (12)
Malaria. Principles and practice of malariology. Volumes 1 and 2. (1988) (11)
Gender-specific distribution of mefloquine in the blood following the administration of therapeutic doses (2013) (11)
High antitrypanosomal activity of plant-derived sulphur-containing amides. (2010) (11)
In vitro assessment of sensitivity of Plasmodium falciparum to chloroquine and mefloquine in Ghana. (1985) (11)
The anaemia of malaria. (1988) (11)
Genetics of malaria parasites. (1988) (11)
Clinical diagnosis of malaria: can the patients help us improve? (1996) (10)
Comparative study on the in vitro activity of lumefantrine and desbutyl-benflumetol in fresh isolates of Plasmodium vivax from Thailand. (2004) (10)
Global challenges of changing epidemiological patterns of malaria. (2012) (10)
Anti-leishmanial activity of plant-derived acridones, flavaglines, and sulfur-containing amides. (2011) (10)
Single-dose comparative kinetics and bioavailability study of quinine hydrochloride, quinidine sulfate and quinidine bisulfate sustained-release in healthy male volunteers. (1988) (10)
Comparison of the in-vitro activity of amodiaquine and its main metabolite, monodesethyl-amodiaquine, in Plasmodium falciparum. (2003) (10)
Pharmacokinetics of mefloquine in children aged 6 to 24 months (1992) (10)
A phase II/III double-blind, dose-finding clinical trial of a combination of mefloquine, sulfadoxine, and pyrimethamine (Fansimef) in falciparum malaria. (1987) (10)
Current approaches to malaria chemotherapy and prophylaxis. (1986) (9)
Drug resistant malaria. (1984) (9)
In-vitro response of Plasmodium falciparum to the main alkaloids of Cinchona in northwestern Thailand. (2003) (9)
The malaria situation in 1975. (1976) (9)
Susceptibility to chloroquine, mefloquine and artemisinin of Plasmodium vivax in northwestern Thailand (2007) (9)
Comparative study of the in vitro sensitivity of Plasmodium falciparum to artemisinin in two border areas of Thailand. (2004) (8)
Malaria in paediatric practice. (1988) (8)
Pharmacodynamic interaction between mefloquine and retinol in Plasmodium falciparum in vitro (2009) (8)
INTRAMUSCULAR CHLOROQUINE IN CHILDREN (1984) (8)
Specific acquired immunity in experimental malaria. (1988) (8)
Decreasing chloroquine resistance in Plasmodium falciparum isolates from Gabon. (2000) (8)
Malaria control priorities and constraints. (1999) (8)
Clinical and parasitological response of Plasmodium falciparum to chloroquine and sulfadoxine/pyrimethamine in rural Uganda. (2003) (8)
Severe orthostatic hypotension during treatment of falciparum malaria (1988) (8)
Sensitivity of Plasmodium vivax to chloroquine, mefloquine, artemisinin and atovaquone in north-western Thailand (2011) (8)
Synergism of desbutyl-benflumetol and retinol against Plasmodium falciparum in vitro (2005) (7)
Serum laminin in malaria. (1994) (7)
Interaction between lumefantrine and monodesbutyl-benflumetol in Plasmodium falciparum in vitro (2008) (7)
Specific pharmacokinetic interaction between lumefantrine and monodesbutyl-benflumetol in Plasmodium falciparum (2007) (7)
Synergism between mefloquine and artemisinin and its enhancement by retinol in Plasmodium falciparum in vitro (2010) (7)
The use of drugs for malaria control. (1988) (7)
In vitro response of Plasmodium falciparum to mefloquine. Studies conducted in West and East Africa. (1985) (7)
Multiple-dose pharmacokinetic study of proguanil and cycloguanil following 12-hourly administration of 100 mg proguanil hydrochloride. (1990) (6)
Learning from history (2009) (6)
In-vitro sensitivity testing of Plasmodium vivax: response to lumefantrine and chloroquine in northwestern Thailand. (2003) (6)
Development of a pharmacodynamic screening model with Entamoeba histolytica (2007) (6)
Field research in the context of malaria control. (1988) (6)
Malaria control constraints. (1988) (6)
Pharmacodynamic interaction between atovaquone and other antimalarial compounds against Plasmodium falciparum in vitro (2006) (6)
Transfusion malaria and other forms of induced malaria. (1988) (6)
Development of a pharmacodynamic screening model with Crithidia fasciculata (2006) (6)
The immunodiagnosis of malaria. (1988) (6)
Chloroquine dosage for prevention of malaria mortality and the use of primaquine to slow down the spread of resistance. (1985) (6)
[Longitudinal sero-epidemiologic study of malaria in Tunisia]. (1976) (6)
Towards a malaria vaccine - discussion. (1985) (6)
Malariological baseline survey and in vitro antimalarial drug resistance in Gulu district, Northern Uganda (2008) (5)
In vitro interaction between artemisinin and chloroquine as well as desbutyl-benflumetol in Plasmodium vivax (2006) (5)
In vitro sensitivity of Plasmodium falciparum to lumefantrine in north-western Thailand. (2004) (5)
Drug sensitivity of Plasmodium falciparum along the Thai–Myanmar border using the new field-deployable HRP2 in vitro assay (2005) (5)
Malaria in infants whose mothers received chemoprophylaxis: response to amodiaquine therapy. (1992) (5)
Protection against malaria among seafarers. (2002) (5)
Long-term aims of malaria research (1979) (5)
Distribution of mefloquine in the blood of Thai patients with acute uncomplicated falciparum malaria following administration of therapeutic doses of artesunate (2011) (5)
Evaluation of an in vitro test method for the assessment of sensitivity of Plasmodium falciparum to pyrimethamine and sulfadoxine. (1987) (5)
Synergism between quinine and retinol in fresh isolates of Plasmodium falciparum (2008) (5)
In vitro cultivation of malaria parasites: sporogonic stages. (1988) (5)
Synergism between pyronaridine and retinol in Plasmodium falciparum in vitro (2009) (5)
Synergistic interaction between atovaquone and retinol in Plasmodium falciparum in vitro (2007) (4)
New developments in malaria chemotherapy using in vitro cultures. (1980) (4)
Synergism between monodesbutyl-benflumetol and artemisinin in Plasmodium falciparum in vitro (2008) (4)
In vitro drug sensitivity testing in Plasmodium vivax (2008) (4)
In-vitro interaction of tafenoquine and chloroquine in Plasmodium falciparum from northwestern Thailand. (2003) (4)
The role of cell-mediated immune responses in protection against plasmodia and in the pathogenesis of malaria. (1988) (4)
Mixed-species malaria infection in high transmission areas of Thailand (2008) (4)
Prospects for the development of malaria vaccines. (1981) (4)
Drug Sensitivity of Plasmodium falciparum and Plasmodium vivax in the area of Mae Sot, Tak Province, northwestern Thailand (2007) (3)
The chemical pathology of malaria. (1988) (3)
Quinine in health care in the tropics. (1987) (3)
Biological characterization of malaria parasites. (1988) (3)
Membranes of malaria parasites and host cells: structure and function. (1988) (3)
Chemoprophylaxis of malaria: underlying principles and their realization. (1990) (3)
Pharmacodynamic interaction between 4-aminoquinolines and retinol in Plasmodium falciparum in vitro (2008) (3)
Urgent efforts needed to combat drug-resistant malaria. (1983) (3)
Synergistic interaction between monodesbutyl-benflumetol and retinol in Plasmodium falciparum (2007) (3)
Pharmacodynamic interaction between lumefantrine and desbutyl-benflumetol in Plasmodium falciparum in vitro (2010) (3)
Handling, preservation, storage and transportation of biological materials. (1988) (2)
The orientation of immunological research in relation to the global antimalaria programme. (1979) (2)
Pharmacodynamic interaction between monodesbutyl-benflumetol and artemisinin as well as proguanil in Plasmodium falciparum in vitro (2008) (2)
Investigation of the in vitro gender-specific partitioning of mefloquine in malarial infected red blood cells and plasma. (2013) (2)
Handling, preservation, storage and transportation of malaria parasites. (1988) (2)
The relevance of research to the global antimalaria programme. (1977) (2)
Relationships between mefloquine blood levels, gender, and adverse reactions. (2002) (2)
Desbutyl-Benﬂumetol, a Novel Antimalarial Compound: In Vitro Activity in Fresh Isolates of Plasmodium falciparum from Thailand (2001) (2)
On the use of antimalarials. (1990) (2)
Predictive role of laboratory and clinical treatment response parameters and glucose-6-phosphate dehydrogenase status in the therapy of falciparum malaria. (2002) (2)
In vitro tests for drug resistance in Plasmodium falciparum (2012) (1)
Gender-specific distribution of mefloquine in the blood following the administration of therapeutic doses (2013) (1)
Pyronaridine (1996) (1)
Criteria for the in-vitro response of Plasmodium falciparum to amodiaquine. (1989) (1)
Synergism between pyronaridine and retinol in Plasmodium vivax in vitro (2010) (1)
In vitro studies on the sensitivity to artemisinin in Plasmodium falciparum at Mae Hong Son, Thailand, 1994-1999. (2000) (1)
Clinical features, aetiology and short-term outcome of interstitial pneumonitis in HIV/AIDS patients at Bamrasnaradura Hospital, Nonthaburi, Thailand (2005) (1)
Isolation and purification of malaria parasites and their antigens. (1988) (0)
Drug resistance in malaria. Malaria prophylaxis. (1980) (0)
Clinical diagnosis of malaria: a reply (1996) (0)
Papers of the 36th annual meeting of the Austrian Society for Tropical Medicine and Parasitology. (2003) (0)
Aims, concepts and recent results of research on malaria parasites. (1984) (0)
Strategies in the fight against parasites. (1988) (0)
Erratum to: Synergism between pyronaridine and retinol in Plasmodium falciparum in vitro (2009) (0)
The changing role of drugs in malaria control (1990) (0)
6 | le arning F roM hi Story (2009) (0)
Comparative multiple dose pharmacokinetics of quinine, quinidine and quinidine sustained release. (1989) (0)
CLINICAL DIAGNOSIS OF MALARIA. AUTHOR'S REPLY (1996) (0)
Drug resistance, current studies and future prospects. (1982) (0)
1330 – THE ROLE OF THE WORLD HEALTH ORGANIZATION IN THE DEVELOPMENT OF NEW ANTIMALARIALS (1978) (0)
Scientific development since the discovery of Laveran. Present position of malaria control in the world. (1980) (0)
In vitro sensitivity to mefloquine of Plasmodium falciparum in northwestern Thailand, 1999. (2000) (0)
Use of quinine allegedly a "WHO-policy". (1987) (0)
Plasmodial antigens implicated in stage-specific immune protection. (1988) (0)
In vitro microtest for chloroquine resistance of Plasmodium falciparum. (1988) (0)
[Advantages and disadvantages of different concepts of malaria prevention]. (1985) (0)
Halofantrine sensitivity (1993) (0)
Mise au point de vaccins antipaludiques: perspectives. (1981) (0)
The Role of the World Health Organization in the Development of New Antimalarials (1979) (0)
In vitro culture of Plasmodium falciparum and its use for the determination of drug sensitivity. (1980) (0)
Sensitivity to artemisinin of Plasmodium falciparum from muheza, Northeastern Tanzania, and Mae Hong son, Northwestern Thailand (1998) (0)
Evasion of host immunity in malaria infections. (1988) (0)
Problems of the World Health Organization with regard to imported diseases. (1980) (0)
Alternative treatment of drug resistant falciparum malaria with particular reference to Africa south of the Sahara. (1985) (0)
A double-blind clinical trial ofacombination of mefloquine, sulfadoxine andpyrimethamine insymptomatic falciparum malaria (1985) (0)

This paper list is powered by the following services:

What Schools Are Affiliated With Walther Helmut Wernsdorfer?

Walther Helmut Wernsdorfer is affiliated with the following schools:

Walther Helmut Wernsdorfer's Academic­Influence.com Rankings

Why Is Walther Helmut Wernsdorfer Influential?

Walther Helmut Wernsdorfer's Published Works

Published Works

What Schools Are Affiliated With Walther Helmut Wernsdorfer?

Walther Helmut Wernsdorfer's AcademicInfluence.com Rankings